PATENT CLAIM ANALYSIS

Application Number: 15946120
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["546", "268700"]

Abstract:
The present invention relates to a compound of formula (I): wherein A and A′ independently represent a phenylene group or a pyridylene group; R 2  is a hydrogen atom or a (C 1 -C 4 )alkyl group; R 3  is a 2-pyridyl group, 3-pyridyl group, a 4-pyridyl group, a 2-pyrimidinyl group, a 4-pyrimidinyl group or a 5-pyrimidinyl group; R 4  is a carbonyl group or a sulfonyl group; and R 5  is a —NH—(CH 2 ) a —NR 6 R 7  group or a 4-methylpiperazinyl group, with a being an integer from 1 to 4, R 6  and R 7  representing independently a (C 1 -C 4 )alkyl group, or R 6  and R 7  together with the nitrogen atom to which they are linked forming a heterocycle group which is chosen among a 4-methylpiperazinyl group, a morpholino group, a pyrrolidinyl group and a piperidino group; or any one of its pharmaceutically acceptable salt.

Claim (Index 9):
The compound of formula (I) according to  claim 1  chosen among\n N-(3-morpholinopropyl)-3-((3-(pyridin-4-ylcarbamoyl)phenyl) amino)benzamide; \n N-(pyridin-4-yl)-3-((3-((3-(pyrrolidin-1yl)propyl)carbamoyl)phenyl)amino)benzamide; \n N-(3-(4-methylpiperazin-1-yl)propyl)-3-((3-(pyridin-4-ylcarbamoyl)phenyl) amino)benzamide; \n N-(3-(piperidin-1-yl)propyl)-3-((3-(pyridin-4-ylcarbamoyl)phenyl)amino) benzamide; \n 3-((3-(4-methylpiperazine-1-carbonyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n 3-((3-(N-(3-(piperidin-1-yl)propyl)sulfamoyl)phenyl)amino)-N-(pyridin-4-yl) benzamide; \n 3-((3-(N-(2-(piperidin-1-yl)ethyl)sulfamoyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n 3-((3-(N-(3-morpholinopropyl)sulfamoyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n N-(3-morpholinopropyl)-3-((4-(pyridin-4-ylcarbamoyl)phenyl)amino) benzamide; \n 4-((3-(N-(3-morpholinopropyl)sulfamoyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n N-(pyridin-4-yl)-4-((3-(N-(2-(pyrrolidin-1-yl)ethyl)sulfamoyl)phenyl)amino)benzamide; \n N-methyl-N-(pyridin-4-yl)-3-((3-((3-(pyrrolidin-1-yl)propyl)carbamoyl) phenyl)amino)benzamide; \n N-methyl-3-((3-((3-(4-methylpiperazin-1-yl)propyl)carbamoyl)phenyl) amino)-N-(pyridine-4-yl) benzamide; \n N-methyl-3-((3-((3-(piperidin-1-yl)propyl)carbamoyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n N-methyl-3-((3-((3-morpholinopropyl)carbamoyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n N-methyl-3-((3-(N-(3-morpholinopropyl)sulfamoyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n N-methyl-3-((3-(N-(3-(piperidin-1-yl)propyl)sulfamoyl)phenyl)amino)-N-(pyridin-4-yl)benzamide; \n 3-((3-(N-(3-(piperidin-1-yl)propyl)sulfamoyl)phenyl)amino)-N-(pyrimidin-4-yl)benzamide; \n N-(pyrimidin-4-yl)-3-((3-((3-(pyrrolidin-1-yl)propyl)carbamoyl)phenyl) amino)benzamide; \n N-(3-(piperidin-1-yl)propyl)-3-((3-(pyrimidin-4-ylcarbamoyl)phenyl)amino)benzamide; \n N-(3-morpholinopropyl)-3-((3-(pyrimidin-4-ylcarbamoyl)phenyl)amino)benzamide; N-(3-(4-methylpiperazin-1-yl)propyl)-3-((3-(pyrimidin-4-ylcarbamoyl) phenyl)amino)benzamide;\n and their pharmaceutically acceptable salts.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 91.0
- Lexical Diversity: 2.28205
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14432328', '14009283', '13377760', '14902935', '14256334']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8016459832953449
- 35 USC 102 Novelty (BERT): 0.6075374068742555
- Combined Prediction Score: 0.7822351256532359
- Mean Citation Score: 402.23895000000016
- Max Citation Score: 559.0132
- Similarity Product: 492.35594077360633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test